Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children

Bibliography

• Cox FM, Cobb MM, Chua WQ, et al. Cost of treating influenza in emergency department and hospital settings. Am J Manag Care 2000;6(2):205-14
   PubMedGoogle Scholar
• Neuzil KM, Reed GW, Mitchel EF, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. J Am Med Assoc 1999;281(10):901-7
   PubMed Web of Science ®Google Scholar
• Szucs T. The socio-economic burden of influenza. J Antimicrob Chemother 1999;44(Suppl B):11-5
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004;190(8):1369-73
   PubMed Web of Science ®Google Scholar
• Sullivan KM. Health impact of influenza in the United States. Pharmacoeconomics 1996;9(Suppl 3):26-33; discussion 50-3
   PubMedGoogle Scholar
• Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 1998;48(2):85-90
   PubMed Web of Science ®Google Scholar
• Bettis R, Iacuzio D, Jung T, et al. Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents. Clin Drug Investig 2006;26(6):329-40
   PubMed Web of Science ®Google Scholar
• Lee PY, Matchar DB, Clements DA, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 2002;137(4):225-31
   PubMed Web of Science ®Google Scholar
• Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics 2006;118(6):2409-17
   PubMed Web of Science ®Google Scholar
• Keren R, Zaoutis TE, Saddlemire S, et al. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 2006;118(5):e1321-7
   Web of Science ®Google Scholar
• Jefferson T, Demicheli V, Rivetti D, Jones M, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006;367(9507):303-13
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283(8):1016-24
   PubMed Web of Science ®Google Scholar
• Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326(7401):1235
   PubMed Web of Science ®Google Scholar
• Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282(13):1240-6
   PubMed Web of Science ®Google Scholar
• Matheson N, Harnden A, Perera R, et al. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2007;1:CD002744
   Google Scholar
• Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20(2):127-33
   PubMed Web of Science ®Google Scholar
• Nordstrom BL, Sung I, Suter P, Szneke P. Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Curr Med Res Opin 2005;21(5):761-8
   PubMed Web of Science ®Google Scholar
• Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163(14):1667-72
   PubMed Web of Science ®Google Scholar
• Barr CE, Schulman KS, Iacuzio D, Bradley JS. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin 2007;23(3):523-31
   PubMed Web of Science ®Google Scholar
• Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001;161(5):749-59
   PubMed Web of Science ®Google Scholar
• McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993;153(18):2105-11
   PubMed Web of Science ®Google Scholar
• Avritscher EB, Cooksley CD, Geraci JM, et al. Cost-effectiveness of influenza vaccination in working-age cancer patients. Cancer; 2007
   PubMedGoogle Scholar
• Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000;284(13):1655-63
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003;139(5 Pt 1):321-9
   PubMed Web of Science ®Google Scholar
• Vindt Holm M, Gyldmark M, Holme Hansen E. Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults. Pharm World Sci 2004;26(6):339-45
   PubMedGoogle Scholar
• Roche. Tamiflu. Summary of product characteristics. Nutley, NJ: Roche; 2006
   Google Scholar
• Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46(10):1075-9; discussion 81-90
   PubMed Web of Science ®Google Scholar
• Heckmann JJ, Ichimura H, Todd P. Matching as an econometric evaluation estimator: evidence from evaluating a job training programme. Rev Econ Stud 1997;64:604-54
   Google Scholar
• Easing the burden: the challenge of managing influenza. Am J Manag Care 2000;6:S276-81
   Google Scholar
• Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342(4):225-31
   PubMed Web of Science ®Google Scholar
• Ciesla G, Leader S, Stoddard J. Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997 – 2001. Respir Med 2004;98(11):1093-101
   PubMed Web of Science ®Google Scholar
• Stürmer T, Joshi M, Glynn RJ, et al. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006;59:437-47
   PubMed Web of Science ®Google Scholar
• Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999;150:327-33
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Boston R, Farrar JT, Strom BL. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 2003;158:280-7
   PubMed Web of Science ®Google Scholar
• Montalto NJ. An office-based approach to influenza: clinical diagnosis and laboratory testing. Am Fam Physician 2003;67(1):111-8
   PubMed Web of Science ®Google Scholar
• Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003;51(1):123-9
   PubMed Web of Science ®Google Scholar